Vivos Therapeutics Announces Pricing Of $4M Private Placement Priced At-the-Market Under Nasdaq Rules
Portfolio Pulse from Benzinga Newsdesk
Vivos Therapeutics (NASDAQ:VVOS) has announced a private placement of 980,393 shares at $4.08 per share, priced at-the-market under Nasdaq rules. The company will also issue a five-year Series A Warrant and an 18-month Series B Warrant to purchase up to an aggregate of 980,393 shares of common stock each. The gross proceeds from the offering are expected to be approximately $4.0 million, which will be used for general corporate purposes. The closing of the private placement is expected to occur on November 2, 2023.
October 31, 2023 | 12:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vivos Therapeutics is raising approximately $4.0 million through a private placement. This could provide the company with the necessary funds for its operations, potentially strengthening its financial position.
The private placement will provide Vivos Therapeutics with additional capital, which can be used for general corporate purposes. This could potentially strengthen the company's financial position, making it more attractive to investors and potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100